GR3005998T3 - - Google Patents
Info
- Publication number
- GR3005998T3 GR3005998T3 GR920402317T GR920402317T GR3005998T3 GR 3005998 T3 GR3005998 T3 GR 3005998T3 GR 920402317 T GR920402317 T GR 920402317T GR 920402317 T GR920402317 T GR 920402317T GR 3005998 T3 GR3005998 T3 GR 3005998T3
- Authority
- GR
- Greece
- Prior art keywords
- diltiazem
- nifedipine
- verapamil
- stroke
- activity
- Prior art date
Links
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 abstract 1
- 229960004166 diltiazem Drugs 0.000 abstract 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 abstract 1
- 229960001597 nifedipine Drugs 0.000 abstract 1
- 229960001722 verapamil Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/818,505 US4654372A (en) | 1986-01-10 | 1986-01-10 | Method for using verapamil for treating stroke |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3005998T3 true GR3005998T3 (enExample) | 1993-06-07 |
Family
ID=25225695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR920402317T GR3005998T3 (enExample) | 1986-01-10 | 1992-10-15 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4654372A (enExample) |
| EP (1) | EP0229644B1 (enExample) |
| JP (1) | JPS62167725A (enExample) |
| AT (1) | ATE81006T1 (enExample) |
| CA (1) | CA1284950C (enExample) |
| DE (1) | DE3781904T2 (enExample) |
| ES (1) | ES2046178T3 (enExample) |
| GR (1) | GR3005998T3 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4871731A (en) * | 1987-10-07 | 1989-10-03 | Marion Laboratories, Inc. | Captopril and diltiazem composition and the like |
| DE3737741A1 (de) * | 1987-11-06 | 1989-05-18 | Goedecke Ag | Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid |
| DK0429676T3 (enExample) * | 1989-06-16 | 1997-03-10 | Santen Pharmaceutical Co Ltd | |
| RU1804845C (ru) * | 1991-02-15 | 1993-03-30 | Институт Органического Синтеза Латвийской Ан | Ноотропное вещество |
| US6083532A (en) | 1995-03-01 | 2000-07-04 | Duramed Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers and tablet formed therefrom |
| US5695781A (en) * | 1995-03-01 | 1997-12-09 | Hallmark Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers |
| KR20040078140A (ko) * | 1998-07-10 | 2004-09-08 | 노파르티스 아게 | 발사르탄 및 칼슘 채널 차단제의 항고혈압 병용 제제 |
| US20100041691A1 (en) * | 2006-09-12 | 2010-02-18 | Neurosearch A/S | Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein |
| WO2020157122A1 (en) * | 2019-01-29 | 2020-08-06 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Treating the causative agent in adhesiogenesis |
| IL297333B2 (en) * | 2020-04-17 | 2025-09-01 | Honeybrains Llc | Preparations and methods for treating neuropsychiatric disorders |
| WO2026002967A1 (en) | 2024-06-24 | 2026-01-02 | Universität Linz | Leoligin and derivatives thereof as calcium channel blockers for the prevention and/or treatment of related diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4568677A (en) * | 1983-07-23 | 1986-02-04 | Pfizer Inc. | 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents |
| JPS60130517A (ja) * | 1983-12-16 | 1985-07-12 | Mitsui Pharmaceut Inc | アレルギ−性鼻炎治療剤 |
-
1986
- 1986-01-10 US US06/818,505 patent/US4654372A/en not_active Expired - Fee Related
- 1986-11-07 CA CA000522469A patent/CA1284950C/en not_active Expired - Fee Related
-
1987
- 1987-01-09 ES ES87100195T patent/ES2046178T3/es not_active Expired - Lifetime
- 1987-01-09 EP EP87100195A patent/EP0229644B1/en not_active Expired - Lifetime
- 1987-01-09 DE DE8787100195T patent/DE3781904T2/de not_active Expired - Fee Related
- 1987-01-09 JP JP62001981A patent/JPS62167725A/ja active Pending
- 1987-01-09 AT AT87100195T patent/ATE81006T1/de not_active IP Right Cessation
-
1992
- 1992-10-15 GR GR920402317T patent/GR3005998T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE3781904T2 (de) | 1993-02-25 |
| ES2046178T3 (es) | 1995-04-01 |
| US4654372A (en) | 1987-03-31 |
| JPS62167725A (ja) | 1987-07-24 |
| EP0229644A3 (en) | 1989-11-23 |
| CA1284950C (en) | 1991-06-18 |
| DE3781904D1 (de) | 1992-11-05 |
| EP0229644B1 (en) | 1992-09-30 |
| ATE81006T1 (de) | 1992-10-15 |
| EP0229644A2 (en) | 1987-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA08581A (en) | Treatment of diseases caused by retroviruses. | |
| ZA87219B (en) | 4,5,6-substituted-n-(substituted-phenyl)-2-pyrimidinamines | |
| NO167122C (no) | Implanterbar kneprotese. | |
| FI863135A7 (fi) | Proteesi, joka omaa parannetun luuhun kiinnittymisen. | |
| NO872212D0 (no) | Freseverktoey for trebearbeidning. | |
| NO875487D0 (no) | Fremgangsmaate for selektiv behandling av en undergrunnsformasjon. | |
| EP0229644A3 (en) | Method of use for diltiazem, verapamil or nifedipine having activity for the treatment of stroke | |
| FI874166L (fi) | Anvaendning av 2',3'-dideoxicytidin -2'-en foer behandling av patienter infekterade med retrovirus. | |
| IT8619378A0 (it) | Procedimento per omopolimerizzazione anionica di alfa-trifluorometilacrilato. | |
| PL266932A1 (en) | The method of manufacture of new 1,4-benzodiasepine | |
| IT8820342A0 (it) | Procedimento per la realizzazione di un corpo cavo. | |
| ES2022208B3 (es) | Agarre para un portaherramientas de una maquina-herramienta. | |
| DE3783013D1 (de) | Elektrolytisches fertigbearbeitungsverfahren. | |
| EP0430551A3 (en) | Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds | |
| DK671087A (da) | Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner som antikonvulsiva | |
| IT8622149A0 (it) | Procedimento per la produzione di gnocchi. | |
| ES2012780B3 (es) | Cierre hermetico del anillo de embolo optimo tribologico | |
| RO95059A (ro) | Procedeu pentru prepararea unor cicloalcancarboxanilide | |
| IT1214310B (it) | Procedimento per il trattamento continuo di tessuti, tessuti a maglia e simili. | |
| IE902286L (en) | Use of isoxazolin-3-one derivatives as antidepressants | |
| IT8819608A0 (it) | Procedimento per la carbocementazione di un pezzo di acciaio. | |
| DE3681026D1 (de) | Oxidierungsverfahren von 2,6-diisopropylnaphthalin. | |
| FI871195A7 (fi) | Menetelmä dihydro-1H-pyrrolitsiini-3,5 -(2H,6H)-dionien valmistamiseksi. | |
| IL69101A0 (en) | Nonapeptide having immunostimulative activity,process for the preparation thereof,and its use | |
| IT8619935A0 (it) | Procedimento per trattare maglieria. |